Broadwood Partners, L.P.: insider buys
Every open-market stock purchase reported by Broadwood Partners, L.P. to the SEC on Form 4.
Broadwood Partners, L.P. has made 3 open-market purchases worth $8.80M in 2 companies since Apr 27, 2026, according to SEC Form 4 filings. The most recent was filed on Nov 19, 2026: 1,000,000 shares of LCTX at $0.77 (Director, 10% Owner), worth $770.70K. The largest was $6M of IMDX on Nov 17, 2026. Taken together, these purchases are down 18% at the latest closing prices (split-adjusted, weighted by amount).
New to insider data? Read how to read a Form 4 and which insider buys matter.
Companies Broadwood Partners, L.P. bought
| Ticker | Company | Role | Buys | Total | Since buy | Last filed |
|---|---|---|---|---|---|---|
| IMDX | Insight Molecular Diagnostics Inc. | 10% Owner | 2 | $8.03M | -21% | Nov 19 |
| LCTX | Lineage Cell Therapeutics, Inc. | Director, 10% Owner | 1 | $770.70K | +6.4% | Nov 19 |
Get the next Broadwood Partners, L.P. purchase on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll purchases
| Filed | Stock | Insider | Value | Shares | Price | Since buy | Stake | Trade | |
|---|---|---|---|---|---|---|---|---|---|
| Nov 19 | LCTXLineage Cell Therapeutics, In… | Broadwood Partners, L.P. +2Director, 10% Owner | $770.70K | 1,000,000 | $0.77 | +6.4% | +2% | Nov 17 | SEC |
| Nov 19 | IMDXInsight Molecular Diagnostics… | Broadwood Partners, L.P. +2private10% Owner | $6M | 3,428,571 | $1.75 | -9.1% | +27% | Nov 17 | SEC |
| Apr 27 | IMDXInsight Molecular Diagnostics… | Broadwood Partners, L.P. +210% Owner | $2.03M | 570,184 | $3.56 | -55% | +5% | Apr 23 | SEC |